youtube_live
Q3 2026 earnings • 11:30 PM today
See detailschevron_right
GH:NASDAQ
Guardant Health Inc
US$156,48
arrow_downward
-7,18%(-12,10) 1D
5 ພ.ຈ., 10 ໂມງ 36 ນາທີ 40 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
US$165,00
High
US$165,10
Low
US$155,18
Mkt. cap
21,00 ຕື້
Avg. vol.
1,81 ລ້ານ
Volume
668,54 ພັນ
52-wk high
US$191,01
52-wk low
US$74,55
EPS
US$-3,50
Beta
1,67
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
Open
US$165,00
High
US$165,10
Low
US$155,18
Mkt. cap
21,00 ຕື້
Avg. vol.
1,81 ລ້ານ
Volume
668,54 ພັນ
52-wk high
US$191,01
52-wk low
US$74,55
EPS
US$-3,50
Beta
1,67
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
Yahoo! Finance Canada
·
10 ຊົ່ວໂມງກ່ອນ
Will Shield Award Recognition Change Guardant Health Stock Narrative
Zacks
·
17 ຊົ່ວໂມງກ່ອນ
Cytokinetics (CYTK) Reports Q3 Loss, Beats Revenue Estimates
Investing.com India
·
2 ມື້ກ່ອນ
Form 8K Guardant Health Inc For: 3 November By Investing.com
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 ພັນ
Founded2012
HeadquartersPalo Alto, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorHealth care provider
Industry-
Websiteguardanthealth.com